21 process-engineering-"https:"-"https:"-"https:"-"https:"-"https:" positions at Newcastle University
Sort by
Refine Your Search
-
the difference between Home and International fees. International applicants may require an ATAS (Academic Technology Approval Scheme ) clearance certificate prior to obtaining their visa and to study on
-
the difference between Home and International fees. International applicants may require an ATAS (Academic Technology Approval Scheme ) clearance certificate prior to obtaining their visa and to study on
-
(Academic Technology Approval Scheme ) clearance certificate prior to obtaining their visa and to study on this programme. How To Apply You must apply through the University’s Apply to Newcastle Portal Once
-
criteria). International applicants are welcome to apply but will be required to cover the difference between Home and International fees. International applicants may require an ATAS (Academic Technology
-
, purified and tested for biological activity together, in a single operation taking as little as a week. You will apply this new approach to real drug targets in cancer, working at the interface of synthetic
-
this: new chemistry methods that let around 100 candidate compounds be made, purified and tested for biological activity together, in a single operation taking as little as a week. You will apply this new
-
relevant subject, such as health sciences, biomedical engineering, or related discipline. A strong interest in implementation science, innovation adoption, or health systems research is essential, alongside
-
residency criteria). International applicants are welcome to apply but will be required to cover the difference between Home and International fees. International applicants may require an Academic Technology
-
Neurodiversity is an umbrella term for people processing information in different ways. This variability is natural; all neurotypes are equally valued. There are many types, for example autism, ADHD, dyslexia
-
Mitochondrial diseases are among the most common inherited metabolic disorders. Despite advances in genetic diagnosis, important questions remain regarding the processes that drive disease progression and